Mineo Kurokawa Selected Research

Mineo Kurokawa Research Topics

Disease

44	Neoplasms (Cancer) 01/2024 - 03/2005
39	Leukemia 10/2021 - 01/2003
22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 12/2004
21	Lymphoma (Lymphomas) 12/2022 - 08/2006
20	Infections 04/2023 - 01/2003
18	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2019 - 04/2002
14	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2005
13	Acute Promyelocytic Leukemia 08/2023 - 10/2008
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2019 - 03/2003
11	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2023 - 03/2010
10	Neutropenia 12/2023 - 03/2010
10	Aplastic Anemia (Anemia, Hypoplastic) 05/2023 - 01/2007
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 02/2007
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 08/2009
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 12/2003
8	Multiple Myeloma 05/2023 - 10/2007
8	Philadelphia Chromosome 09/2022 - 11/2010
7	Thrombocytopenia (Thrombopenia) 09/2023 - 03/2010
6	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2024 - 05/2008
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 10/2008
6	Febrile Neutropenia 02/2022 - 10/2020
6	Disease Progression 08/2020 - 05/2007
6	Hematologic Diseases (Blood Diseases) 08/2015 - 06/2009
5	Sepsis (Septicemia) 07/2018 - 04/2014
5	Fever (Fevers) 04/2015 - 03/2008
4	Carcinogenesis 09/2022 - 09/2005
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2022 - 11/2011
4	Inflammation (Inflammations) 01/2016 - 10/2008
3	Hemorrhage 02/2024 - 11/2007
3	Pleural Effusion (Pleural Effusions) 01/2024 - 01/2010
3	Bronchiolitis Obliterans Syndrome 01/2024 - 03/2012
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2023 - 11/2006
3	Plasmacytoma 07/2023 - 10/2016
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2023 - 01/2013
3	Leukocytosis (Pleocytosis) 05/2023 - 12/2018
3	Bacteremia 04/2023 - 11/2017
3	Edema (Dropsy) 03/2023 - 03/2011
3	Chromosome Aberrations (Chromosome Abnormalities) 03/2023 - 12/2011
3	Hodgkin Disease (Hodgkin's Disease) 12/2022 - 06/2014
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2022 - 09/2010
3	Dermatitis 09/2022 - 07/2015
3	Encephalitis (Encephalitis, Rasmussen) 02/2022 - 06/2008
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 01/2013
3	Erdheim-Chester Disease 05/2021 - 01/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2018
3	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2009
3	Insulin Resistance 01/2020 - 04/2011
3	Obesity 01/2020 - 04/2011
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2018 - 02/2016
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2018 - 02/2014
3	Residual Neoplasm 01/2018 - 11/2006

Drug/Important Bio-Agent (IBA)

17	Transcription Factors (Transcription Factor)IBA 09/2022 - 01/2003
13	Rituximab (Mabthera)FDA Link 10/2021 - 02/2007
12	Proteins (Proteins, Gene)FDA Link 03/2023 - 04/2002
9	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022 - 08/2007
8	Prednisolone (Predate)FDA LinkGeneric 09/2023 - 08/2006
8	Imatinib Mesylate (Gleevec)FDA Link 11/2022 - 09/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021 - 08/2006
8	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2013
7	Inosine Triphosphate (ITP)IBA 05/2023 - 07/2011
7	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 06/2009
6	Dexamethasone (Maxidex)FDA LinkGeneric 04/2023 - 03/2010
6	Messenger RNA (mRNA)IBA 12/2018 - 11/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2003
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2012
5	SteroidsIBA 09/2023 - 03/2012
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 07/2013
5	AntigensIBA 01/2018 - 04/2007
4	Lenalidomide (CC 5013)FDA Link 07/2023 - 01/2013
4	Bendamustine Hydrochloride FDA Link 01/2023 - 04/2015
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2022 - 03/2009
4	HLA Antigens (Human Leukocyte Antigens)IBA 09/2022 - 03/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2008
4	Vincristine (Oncovin)FDA LinkGeneric 06/2021 - 08/2006
4	C-Reactive ProteinIBA 01/2021 - 03/2014
4	nilotinib FDA Link 01/2020 - 03/2011
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 06/2008
4	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 06/2008
4	Biomarkers (Surrogate Marker)IBA 01/2014 - 02/2009
4	Alemtuzumab (Campath)FDA Link 04/2013 - 11/2006
4	Oncogene Proteins (Oncogene Protein)IBA 12/2011 - 05/2005
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 08/2007
3	GlucocorticoidsIBA 01/2022 - 08/2018
3	Small Interfering RNA (siRNA)IBA 10/2021 - 05/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021 - 08/2006
3	FluoroquinolonesIBA 12/2020 - 04/2013
3	Calcineurin InhibitorsIBA 02/2020 - 03/2012
3	Ferritins (Ferritin)IBA 11/2019 - 02/2009

Therapy/Procedure

54	Therapeutics 07/2023 - 05/2006
43	Hematopoietic Stem Cell Transplantation 02/2024 - 11/2006
39	Drug Therapy (Chemotherapy) 12/2023 - 08/2006
24	Transplantation 06/2023 - 03/2003
19	Stem Cell Transplantation 07/2023 - 01/2007
13	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2023 - 03/2003
6	Radiotherapy 03/2023 - 08/2006
6	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2018 - 02/2007
5	Liver Transplantation 12/2023 - 06/2008
5	Cell Transplantation 06/2019 - 09/2014
4	VAP-cyclo protocol 01/2022 - 08/2006
3	Aftercare (After-Treatment) 01/2021 - 02/2011